Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Clinical trial NCT04396223 · RECRUITING
Trial details
- NCT number
- NCT04396223
- Sponsor
- Hospices Civils de Lyon
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2025-04-12
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.